• 2',7'-Dichlorofluorescein Diacetate for ROS Assays

  2026-09-03

  Use 2',7'-Dichlorofluorescein diacetate to connect intracellular redox changes with nanocarrier performance, therapeutic stress, and tumor-cell responses. This practical guide covers assay setup, quantitative workflow design, controls, and troubleshooting for microscopy, flow cytometry, and plate-based ROS measurements.

• MRSA Extracellular Vesicles Drive OSCC via IL-8

  2026-09-03

  This study shows that extracellular vesicles released by methicillin-resistant Staphylococcus aureus (MRSA) can directly promote oral squamous cell carcinoma (OSCC) proliferation and tumor development. Its key mechanistic contribution is the identification of an ERK/c-Jun–IL-8–CXCR1–JAK/STAT5A signaling axis linking antibiotic-resistant bacteria to cancer progression.

• BODIPY 581/591 C11 for Lipid Peroxidation

  2026-09-02

  BODIPY 581/591 C11 converts membrane oxidation into a measurable red-to-green fluorescence shift, enabling quantitative lipid peroxidation detection in live cells and membrane models. This workflow explains how to use its ratiometric design for oxidative stress measurement, antioxidant capacity evaluation, and ferroptosis-related assays while avoiding common interpretation errors.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-09-02

  Translate carbon-ion radiotherapy experiments into reproducible DHODH, ACSL4, and GPX4 protein readouts with an HRP-based ECL workflow. This practical guide covers membrane handling, exposure strategy, assay selection, and troubleshooting for ferroptosis and macrophage-polarization studies.

• Cimetidine: Histamine-2 Receptor Antagonist Assays

  2026-09-01

  Cimetidine supports reproducible H2 receptor, gastrointestinal cancer, and barrier-model experiments through a well-defined solubility and storage profile. This guide translates its partial agonist pharmacology into practical workflows while separating established BBB-model performance from exploratory brain-penetration testing.

• Anti-Inflammatory Lignans from Rosemary Roots

  2026-09-01

  A January 2026 study identified eight lignans and four phenylpropanoids from Rosmarinus officinalis roots, including three previously unreported rosmarinicols. Six compounds suppressed nitric oxide production in LPS-stimulated RAW264.7 macrophages, establishing rosemary roots as a source of chemically diverse anti-inflammatory candidates while defining important limits for mechanistic and translational interpretation.

• CXCR4 Theranostics in Lymphoma: Imaging to Therapy

  2026-08-31

  This 2026 review positions CXCR4 as a theranostic target in lymphoma by connecting receptor-directed PET and SPECT imaging with radioligand, peptide, small-molecule, and antibody therapies. Its main practical contribution is a framework for using CXCR4 expression to support disease characterization, treatment selection, response assessment, and precision oncology while accounting for physiological uptake and compensatory CXCR7 signaling.

• 2-Hydroxypropyl-β-cyclodextrin Protocol Guide

  2026-08-30

  2-Hydroxypropyl-β-cyclodextrin is a water-soluble excipient for screening and formulation workflows involving poorly water-soluble hydrophobic compounds, particularly molecules with aromatic or phenyl groups. It should be evaluated as a solubilization aid in pharmaceutical and biochemical research, not treated as evidence of therapeutic efficacy or validated for unrelated applications.

• TPM3 Khib at Lys141 in Abnormal Vasoconstriction

  2026-08-29

  The reference study identifies HDAC3-mediated removal of 2-hydroxyisobutyrylation from TPM3 Lys141 as a mechanistic link between phenylephrine signaling and excessive vascular smooth muscle contraction. By combining vascular tension assays, coimmunoprecipitation, computational modeling, and TPM3 mutational validation, the work positions TPM3 Khib as a potential regulatory target in hypertensive vascular dysfunction.

• TRPV1/TRPA1 Signaling in Nasal TSLP Production

  2026-08-29

  The reference study identifies a calcium-dependent calcineurin/NFAT mechanism linking TRPV1 and TRPA1 activation to TSLP production in nasal epithelial cells. Its combination of receptor localization, pharmacological perturbation, siRNA, calcium chelation, and NFAT imaging provides a useful framework for studying epithelial ion-channel signaling without equating channel activation with complete airway disease modeling.

• Ceruletide: From Pancreatic Models to Translation

  2026-08-28

  Ceruletide, also known as Caerulein, is more than a secretagogue: it is a controllable perturbation tool for connecting pancreatic injury biology with antifibrotic translation. This article shows how to use the CCK receptor agonist strategically when evaluating MSC-, extracellular vesicle-, and MFGE8-based interventions.

• ECL Chemiluminescent Substrate Detection Kit Guide

  2026-08-28

  Use the ECL Chemiluminescent Substrate Detection Kit to convert HRP-labeled antibody binding into imageable protein signals for pathway validation, including TRIB3, SLC7A11, and GPX4 studies in clear cell renal cell carcinoma. This practical guide combines a membrane-based workflow with exposure control and troubleshooting for reproducible Western blot chemiluminescence detection.

• Thiothixene Drives Macrophage Efferocytosis

  2026-08-27

  A 2025 Science Signaling study identified Thiothixene as a stimulator of apoptotic-cell and lipid-laden-cell clearance by mouse and human macrophages. Its effects were associated with Stra6L-dependent induction of Arginase 1 and improved continual efferocytosis, providing a mechanistic bridge between an established typical antipsychotic agent and inflammatory disease research.

• Golgi-Tracker Green: Live-Cell Workflow

  2026-08-27

  Golgi-Tracker Green enables selective, photostable Golgi imaging in living cells while preserving the dynamics needed for trafficking and sphingolipid studies. This workflow connects organelle morphology with mechanistic assays, including exploratory oncology experiments, without treating a live-cell probe as a fixed-cell stain.

• H-Aggregated NIR-II Fluorophores for Cancer PTT

  2026-08-26

  Yu et al. developed RRIALP-C4, a peptide-coated liposome that transfers H-aggregated IR-1061 from the carrier to tumor cell membranes while co-delivering carboplatin. The design integrates NIR-II fluorescence imaging, membrane-localized photothermal therapy, and temperature-sensitive chemotherapy, providing a mechanistic framework for synergistic cancer theranostics.

455 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page